Literature DB >> 10744077

Expression of C-C chemokines is associated with portal and periportal inflammation in the liver of patients with chronic hepatitis C.

F Kusano1, Y Tanaka, F Marumo, C Sato.   

Abstract

Inflammation of the portal and periportal areas is a common feature of chronic hepatitis C. Antigen-presenting dendritic cells are located in the portal area, and infiltrating T cells are initially exposed to infected hepatocytes in the periportal area. Thus, these areas could be sites of the initial processes of the immune response in chronic hepatitis C. C-C chemokines (dendritic-cell-derived C-C chemokine [DC-CK1] and regulated upon activation, normal T-cell expressed and secreted [RANTES])-attracting T cells may play a role in the portal inflammatory changes. The relationship between the expression of these C-C chemokines, which attract T cells and the infiltration of T cells into the liver of patients with chronic hepatitis C, was examined by in situ hybridization and reverse transcription-polymerase chain reaction. T-cell activation was examined by immunostaining T-cell subsets. Specific signals were detected for DC-CK1 mRNA in mononuclear cells mainly in the portal area and for RANTES mRNA in the portal area and at sites of piecemeal necrosis in the liver of patients with chronic hepatitis C. Naive T cells were located mainly in the portal area, whereas active T cells were found mainly at sites of piecemeal necrosis in the periportal area. In addition, hepatic DC-CK1- and RANTES-mRNA levels were significantly correlated with serum alanine aminotransferase levels (p < 0.001). These results suggest that the local production of DC-CK1 and RANTES participates in immune responses by attracting naive and active T cells to the portal and periportal areas, respectively.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10744077     DOI: 10.1038/labinvest.3780046

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  26 in total

Review 1.  Dendritic cells and immune regulation in the liver.

Authors:  A H Lau; A W Thomson
Journal:  Gut       Date:  2003-02       Impact factor: 23.059

2.  CCL5-28, CCL5-403, and CCR5 genetic polymorphisms and their synergic effect with alcohol and tobacco consumptions increase susceptibility to hepatocellular carcinoma.

Authors:  Hsiu-Ting Tsai; Shun-Fa Yang; Dar-Ren Chen; Szu-Erh Chan
Journal:  Med Oncol       Date:  2012-02-29       Impact factor: 3.064

3.  Hepatitis C virus-induced CCL5 secretion from macrophages activates hepatic stellate cells.

Authors:  Reina Sasaki; Pradip B Devhare; Robert Steele; Ranjit Ray; Ratna B Ray
Journal:  Hepatology       Date:  2017-07-18       Impact factor: 17.425

Review 4.  The role of chemokines in acute and chronic hepatitis C infection.

Authors:  Stephen Fahey; Eugene Dempsey; Aideen Long
Journal:  Cell Mol Immunol       Date:  2013-08-19       Impact factor: 11.530

Review 5.  Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes.

Authors:  Evemie Schutyser; Ann Richmond; Jo Van Damme
Journal:  J Leukoc Biol       Date:  2005-03-22       Impact factor: 4.962

Review 6.  HCV/ HIV co-infection: time to re-evaluate the role of HIV in the liver?

Authors:  J T Blackard; K E Sherman
Journal:  J Viral Hepat       Date:  2008-01-17       Impact factor: 3.728

7.  Chemokine system polymorphisms, survival and hepatocellular carcinoma occurrence in patients with hepatitis C virus-related cirrhosis.

Authors:  Pierre Nahon; Angela Sutton; Pierre Rufat; Chantal Simon; Jean-Claude Trinchet; Liliane Gattegno; Michel Beaugrand; Nathalie Charnaux
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

8.  Differential expression of the CXCR3 ligands in chronic hepatitis C virus (HCV) infection and their modulation by HCV in vitro.

Authors:  Karla J Helbig; Andrew Ruszkiewicz; Robert E Lanford; Mark D Berzsenyi; Hugh A Harley; Shaun R McColl; Michael R Beard
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

Review 9.  Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection.

Authors:  Juan R Larrubia; Selma Benito-Martínez; Miryam Calvino; Eduardo Sanz-de-Villalobos; Trinidad Parra-Cid
Journal:  World J Gastroenterol       Date:  2008-12-21       Impact factor: 5.742

10.  CCL2-2518 A/G and CCR2 190 A/G do not influence the outcome of hepatitis C virus infection in the Spanish population.

Authors:  M-A Montes-Cano; J-R Garcia-Lozano; J Aguilar-Reina; M Romero-Gomez; N Barroso; A Nunez-Roldan; M-F Gonzalez-Escribano
Journal:  World J Gastroenterol       Date:  2007-04-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.